Nicholas B. Argento, MD practices Endocrinology. He went to University of Maryland School of Medicine. University of Maryland School of Medicine has a rank of 37 in research and a 52 in primary care He received awards:"Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Nicholas Argento is also published. He has 3 publications published. The lastest publication: "GLYCEMIC EFFECTS OF SGLT-2 INHIBITOR CANAGLIFLOZIN IN TYPE 1 DIABETES USING DEXCOM G4 PLATINUM CGM.' Nicholas B. Argento, MD is registered with Medicare.
NPI NUMBER | 1093781155 | |
NPPES Provider LastName | ARGENTO | |
NPPES Provider FirstName | NICHOLAS | |
NPPES Provider ZIPCode | 207075203 | |
NPPES Provider State | MD | |
Specialty Description | Endocrinology | |
Total Claim Count | 2610.0 | |
Distinct Opioid Count | 0.0 | |
Opioid Claim Count | 0.0 | |
Percent Opioid Claims | 0.0 |
National Provider Identifier [NPI] | 1093781155 |
Last Name Of The Provider | ARGENTO |
First Name Of The Provider | NICHOLAS |
View All |
Dr. Elizabeth G. Briggs, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Barry K. Lance, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Mark D. Corriere, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Rosalie Naglieri, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Luz C. Tello, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Ann C. Hagen, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Heidi A. Karon, MD
This Doctor is OpenDoctor Recommended. |